L01E Protein kinase inhibitors Protein kinase inhibitors Protein kinase inhibitors Protein kinase inhibitors L3
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L3 · Search this class · Consumer categories
Child classes
L01EABCR-ABL tyrosine kinase inhibitors BCR-ABL tyrosine kinase inhibitors BCR-ABL tyrosine kinase inhibitors BCR-ABL tyrosine kinase inhibitorsL01EBEpidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsL01ECB-Raf serine-threonine kinase (BRAF) inhibitors B-Raf serine-threonine kinase (BRAF) inhibitors B-Raf serine-threonine kinase (BRAF) inhibitors B-Raf serine-threonine kinase (BRAF) inhibitorsL01EDAnaplastic lymphoma kinase (ALK) inhibitors Anaplastic lymphoma kinase (ALK) inhibitors Anaplastic lymphoma kinase (ALK) inhibitors Anaplastic lymphoma kinase (ALK) inhibitorsL01EEMitogen-activated protein kinase (MEK) inhibitors Mitogen-activated protein kinase (MEK) inhibitors Mitogen-activated protein kinase (MEK) inhibitors Mitogen-activated protein kinase (MEK) inhibitorsL01EFCyclin-dependent kinase (CDK) inhibitors Cyclin-dependent kinase (CDK) inhibitors Cyclin-dependent kinase (CDK) inhibitors Cyclin-dependent kinase (CDK) inhibitorsL01EGMammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitorsL01EHHuman epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitorsL01EJJanus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitorsL01EKVascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitorsL01ELBruton's tyrosine kinase (BTK) inhibitors Bruton's tyrosine kinase (BTK) inhibitors Bruton's tyrosine kinase (BTK) inhibitors Bruton's tyrosine kinase (BTK) inhibitorsL01EMPhosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitorsL01ENFibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitorsL01EPCellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitorsL01EXOther protein kinase inhibitors Other protein kinase inhibitors Other protein kinase inhibitors Other protein kinase inhibitors
Active ingredients in this class
132 active ingredients 132 principios activos 132 个活性成分 132 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Dasatinib
L01EA02activeUS GB CA AU SG CN ES MX TW EUdiscontinuedESwithdrawnES EUunknownAU MX HK - Imatinib
L01EA01activeUS GB CA AU SG CN ES MX TW EUdiscontinuedCA ES MXwithdrawnES MX EUunknownAU MX HK - Everolimus
L01EG02activeUS GB CA AU SG CN ES MX TW EUdiscontinuedCA ESwithdrawnES MXunknownAU MX HK - Erlotinib
L01EB02activeUS GB CA AU SG CN ES MX TW EUdiscontinuedCA ES MXwithdrawnES MXunknownAU HK - Gefitinib
L01EB01activeUS GB CA AU SG CN ES MX TW EUdiscontinuedCA ES MXwithdrawnES EUunknownAU MX HK - Lenvatinib
L01EX08activeUS GB CA AU SG CN ES MX TW EUdiscontinuedES MXunknownAU HK - Sorafenib
L01EX02activeUS GB CA AU SG CN ES MX TW EUdiscontinuedES MXwithdrawnESunknownHK - Axitinib
L01EK01activeUS GB CA AU SG CN ES MX TW EUdiscontinuedCAunknownAU MX HK - Ibrutinib
L01EL01activeUS GB CA AU SG CN ES MX TW EUdiscontinuedES MXunknownAU HK - Osimertinib
L01EB04activeUS GB CA AU SG CN ES TW EUdiscontinuedMXunknownAU HK - Fruquintinib
L01EK04activeUS GB CA AU SG CN ES MX TW EUunknownAU HK - Alectinib
L01ED03activeUS GB CA AU SG CN ES TW EUdiscontinuedES MXunknownAU HK - Sunitinib
L01EX01Salt form: Sunitinib MalateactiveUS GB CA AU SG ES MX TW EUdiscontinuedCA ES MXwithdrawnESunknownAU HK - Nilotinib
L01EA03activeUS GB CA AU SG CN ES EUdiscontinuedCA ESunknownAU MX HK - Palbociclib
L01EF01activeUS GB CA AU SG ES MX TW EUdiscontinuedCA ESunknownAU HK - Pazopanib
L01EX03activeUS GB CA AU SG ES MX TW EUdiscontinuedCAunknownAU HK - Brigatinib
L01ED04activeUS GB CA AU SG CN ES TW EUunknownAU HK - Abemaciclib
L01EF03activeUS GB CA AU SG ES TW EUdiscontinuedMXunknownAU HK - Alpelisib
L01EM03activeUS GB CA SG ES MX TW EUunknownAU HK - Dabrafenib
L01EC02activeUS GB CA AU SG CN ES TW EUunknownAU HK - Crizotinib
L01ED01activeUS GB CA AU SG CN ES TW EUunknownAU HK - Entrectinib
L01EX14activeUS GB CA AU SG CN ES TW EUunknownAU HK - Regorafenib
L01EX05activeUS GB CA SG CN ES TW EUunknownAU HK - Capivasertib
L01EX27activeUS GB CA AU SG MX TW EUdiscontinuedESunknownAU HK - Lazertinib
L01EB09activeUS GB CA SG ES MX TW EUunknownAU HK - Zanubrutinib
L01EL03activeUS GB CA AU SG CN ES TW EUdiscontinuedESunknownAU HK - Encorafenib
L01EC03activeUS GB CA AU SG ES MX TW EUunknownAU HK - Ribociclib
L01EF02activeUS GB CA AU SG ES TW EUdiscontinuedMXunknownAU HK - Tucatinib
L01EH03activeUS GB CA SG ES MX TW EUunknownAU HK - Gilteritinib
L01EX13Salt form: Gilteritinib FumarateactiveUS GB CA AU SG CN ES TW EUunknownAU HK - Ripretinib
L01EX19activeUS GB CA AU SG CN ES TW EUunknownAU HK - Neratinib
L01EH02Salt form: Neratinib MaleateactiveUS GB CA SG ES MX TW EUunknownAU HK - Ruxolitinib
L01EJ01activeUS GB CA AU SG ES TW EUdiscontinuedESunknownAU HK - Cabozantinib
L01EX07Salt form: Cabozantinib-MalateactiveGB CA AU SG ES TW EUdiscontinuedES MXunknownAU HK - Selpercatinib
L01EX22activeUS GB CA AU SG ES TW EUdiscontinuedESunknownAU HK - Larotrectinib
L01EX12Salt form: Larotrectinib SulfateactiveUS GB CA AU SG ES TW EUwithdrawnESunknownAU HK - Asciminib
L01EA06Salt form: Asciminib HydrochlorideactiveUS GB CA AU SG ES TW EUdiscontinuedESunknownAU HK - Pemigatinib
L01EN02activeUS GB CA SG ES TW EUunknownAU HK - Ponatinib
L01EA05activeUS GB CA AU SG CN ES EUdiscontinuedCAunknownAU HK - Erdafitinib
L01EN01activeUS GB CA SG ES MX TW EUunknownHK - Acalabrutinib
L01EL02Salt form: Acalabrutinib Maleate MonohydrateactiveUS GB CA AU SG ES TW EUdiscontinuedCA ESunknownAU HK - Dacomitinib
L01EB07activeUS GB SG ES MX TW EUdiscontinuedCA ESunknownHK - Lorlatinib
L01ED05activeUS GB CA AU SG ES TW EUunknownAU HK - Midostaurin
L01EX10activeUS GB CA AU SG ES TW EUunknownAU HK - Inavolisib
L01EM06activeUS GB CA SG ES TW EUunknownAU HK - Binimetinib
L01EE03activeUS GB CA AU SG ES TW EUunknownAU HK - Vemurafenib
L01EC01activeUS GB CA AU SG CN ES TW EUunknownAU - Tepotinib
L01EP02L01EX21Salt form: Tepotinib Hydrochloride MonohydrateactiveUS GB CA AU SG ES TW EUunknownAU HK - Afatinib
L01EB03activeUS GB AU CN ES EUdiscontinuedESunknownMX HK - Bosutinib
L01EA04activeUS GB CA ES MX TW EUdiscontinuedCAunknownAU - Trametinib
L01EE01activeGB CA AU SG CN ES EUdiscontinuedCAunknownHK - Momelotinib
L01EJ04activeUS GB CA AU SG ES EUunknownAU HK - Selumetinib
L01EE04Salt form: Selumetinib SulfateactiveUS GB CA AU SG ES EUdiscontinuedESunknownAU HK - Capmatinib
L01EP01activeUS CA SG ES TW EUunknownAU HK - Pirtobrutinib
L01EL05activeUS GB CA ES TW EUunknownAU HK - Vandetanib
L01EX04activeUS GB CA ES TW EUunknownAU HK - Ceritinib
L01ED02activeUS GB CA AU SG ES TW EUunknownAU - Cobimetinib
L01EE02activeUS GB CA AU SG ES TW EUdiscontinuedESunknownAU - Fedratinib
L01EJ02Salt form: Fedratinib HydrochlorideactiveUS GB CA AU SG ES TW EUunknownAU - Nintedanib
L01EX09activeGB AU SG ES MX EUdiscontinuedESunknownHK - Avapritinib
L01EX18activeUS GB CA ES TW EUunknownHK - Quizartinib
L01EX11activeUS GB CA ES TW EUunknownHK EU - Lapatinib
L01EH01activeGB AU CN ES EUdiscontinuedESunknownMX HK - Futibatinib
L01EN04activeUS GB AU SG ES EUunknownAU HK - Pralsetinib
L01EX23activeUS GB TWdiscontinuedCAwithdrawnES EUunknownHK - Idelalisib
L01EM01activeUS GB CA AU ES EUunknownAU - Repotrectinib
L01EX28activeUS AU TW EUdiscontinuedCAunknownAU HK - Afatinib Dimaleate
L01EB03activeUS CA SG TWdiscontinuedCAunknownAU - Lapatinib Ditosylate
L01EH01activeUS CA SG TWunknownAU - Temsirolimus
L01EG01activeGB CA ES EUdiscontinuedCAwithdrawnESunknownMX - Tivozanib
L01EK03activeUS GB ES EU - Sevabertinib
L01EH06activeUS GB CA TW - Mirdametinib
L01EE05activeUS EUdiscontinuedES - Vimseltinib
L01EX29activeUS EUdiscontinuedES - Tovorafenib
L01EC04activeUS CA EU - Zongertinib
L01EH04activeUS CAunknownHK - Nintedanib Esilate
L01EX09activeCAunknownAU - Infigratinib
L01EN03discontinuedCAunknownAU - Duvelisib
L01EM04activeUSwithdrawnEU - Mobocertinib
L01EB10activeGBwithdrawnEU
Show all 132 (currently showing 80) Mostrar los 132 (ahora se muestran 80) 显示全部 132 个(当前显示前 80 个) 顯示全部 132 個(目前顯示前 80 個)
- Pexidartinib
L01EX15activeUSunknownEU - 哌柏西利
L01EFactiveCN - 乙磺酸尼达尼布
L01EXactiveCN - Anlotinib
L01EKactiveCN - 苹果酸舒尼替尼
L01EXactiveCN - 培唑帕尼
L01EXactiveCN - 富马酸安奈克替尼
L01EXactiveCN - 塞普替尼
L01EXactiveCN - 洛拉替尼
L01EDactiveCN - 甲磺酸阿帕替尼
L01EKactiveCN - 羟乙磺酸达尔西利
L01EFactiveCN - 马来酸奈拉替尼
L01EHactiveCN - 伯瑞替尼
L01EXactiveCN - 甲磺酸阿美替尼
L01EBactiveCN - 盐酸卡马替尼
L01EXactiveCN - 伊鲁阿克
L01EDactiveCN - 阿伐替尼
L01EXactiveCN - 甲磺酸氟马替尼
L01EAactiveCN - 硫酸拉罗替尼
L01EXactiveCN - 普拉替尼
L01EXactiveCN - 琥珀酸瑞波西利
L01EFactiveCN - 马来酸吡咯替尼
L01EHactiveCN - 枸橼酸依奉阿克
L01EDactiveCN - 甲苯磺酸多纳非尼
L01EXactiveCN - 佩米替尼
L01ENactiveCN - 舒沃替尼
L01EBactiveCN - 甲磺酸贝福替尼
L01EBactiveCN - 硫酸艾玛昔替尼
L01EJactiveCN - 盐酸特泊替尼
L01EXactiveCN - 甲磺酸瑞厄替尼
L01EBactiveCN - 度维利塞
L01EMactiveCN - 赛沃替尼
L01EXactiveCN - 盐酸佐利替尼
L01EBactiveCN - 硫酸氢司美替尼
L01EEactiveCN - 利厄替尼
L01EBactiveCN - 伊那利塞
L01EMactiveCN - 妥拉美替尼
L01EEactiveCN - 瑞派替尼
L01EXactiveCN - 己二酸他雷替尼
L01EXactiveCN - 林普利塞
L01EMactiveCN - 伏罗尼布
L01EKactiveCN - 索凡替尼
L01EKactiveCN - 维迪西妥单抗
L01EHactiveCN - 氟泽雷塞
L01EXactiveCN - 甲磺酸瑞齐替尼
L01EBactiveCN - 马来酸阿可替尼
L01ELactiveCN - 戈利昔替尼
L01EJactiveCN - 匹妥布替尼
L01ELactiveCN - 阿可替尼
L01ELactiveCN - 谷美替尼
L01EXactiveCN - Pacritinib
L01EJ03activeUS - 琥珀酸莫博赛替尼
L01EB
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.